<DOC>
	<DOCNO>NCT01899794</DOCNO>
	<brief_summary>The purpose study determine female patient suffer mixed urinary incontinence ( MUI ) follow : 1 ) proportion patient cure improved single modality therapy ( drug surgery alone ) , cure improve combined therapy ( drug surgery order ) non-responders theses therapy ; 2 ) combine therapy sequence ( surgery first , follow oral drug therapy oral drug therapy first , follow surgery ) effective patient need combined therapy .</brief_summary>
	<brief_title>Efficacy Combined Surgical Pharmacological Therapy Treat Mixed Urinary Incontinence .</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Oxybutynin</mesh_term>
	<mesh_term>Mandelic Acids</mesh_term>
	<criteria>1 . Evidence personally sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect trial . 2 . Female outpatient older 18 year . 3 . Naïve* mixed urinary incontinence ( MUI ) consist involuntary urine leakage associate urge incontinence incontinence physical exertion , cough , sneeze , etc . 4 . Positive Cough Stress Test ( CST ) : A positive CST confirm visualization urine leakage external urethral opening , concurrent vigorous cough follow fill bladder capacity 5 . Positive 24hours Pad Test ( PT ) : A positive SPT confirm leakage &gt; 8.0g/24h urine pad place external urethral opening . After 24 hour pad place sealable plastic , weigh urine lose 24h period calculate 6 . Daytime void frequency equal great 8 time per day , night time frequency &gt; 2 time per night . 7 . Subjects willing able comply schedule visit , treatment plan , laboratory test , selfcompletion study questionnaire diary , trial procedure . 8 . Urgency urge incontinence define score overactive bladder symptom score ( OABSS ) &gt; 25 and/or urodynamic signature urge incontinence consist uninhibited detrusor contraction fill phase CMG . Naïve MUI mean patient never receive Oxytrol ( oxybutynin ) surgical treatment condition . 1 . Symptoms MUI &lt; 6 month . 2 . History uncontrolled narrow angle glaucoma . 3 . History relevant neurological disease ( e.g . multiple sclerosis ) . 4 . History low urinary tract anatomical anomaly , e.g. , grade 2 4 urogenital prolapse ( beyond hymen valsalva ) . 5 . History evidence urinary outlet obstruction urinary retention , include post void residual ( PVR ) urine volume &gt; 50ml 6 . Chronic persistent local pathology may cause urinary symptom , e.g . interstitial cystitis , tumour , bladder stone . 7 . Subjects use pharmacological agent device urinary incontinence le 6 week prior inclusion ever use Oxytrol ( oxybutynin ) 8 . Subjects follow condition : 1 . Indwelling urinary catheter perform Intermittent Self Catheterization ( ISC ) 2 . Passive urinary incontinence ( e.g. , vesicovaginal fistula ) . 3 . Not capable independent toileting . 9 . Subjects document untreated UTI ( temporary exclusion ) 10 . Subjects require Hormone Replacement Therapy ( HRT ) must take stable dose least 3 month prior study entry . Any change dose type HRT take study consider protocol violation . 11 . Subjects pregnant lactating . 12 . Subjects uncontrolled narrow angle glaucoma ( opinion treat ophthalmologist require ) . 13 . Subjects ; urodynamic investigation evidence poor bladder compliance and/or neurogenic detrusor hyperactivity . 14 . Subjects opinion investigator trial Clinician , unable and/or unlikely comprehend nature , scope possible consequence study follow study procedure instruction complete study related measurement . This include poor compliance trial medication , subject demonstrate uncooperative behaviour .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>